ALLOGENEIC UMBILICAL-CORD DERIVED MESENCHYMAL STROMAL CELLS MSC(UC) AS TREATMENT FOR SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): SAFETY AND EARLY CLINICAL/BIOLOGICAL RESULTS FROM A PHASE I-II PROOF-OF-CONCEPT CLINICAL STUDY - Archive ouverte HAL
Communication Dans Un Congrès Année : 2024

ALLOGENEIC UMBILICAL-CORD DERIVED MESENCHYMAL STROMAL CELLS MSC(UC) AS TREATMENT FOR SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): SAFETY AND EARLY CLINICAL/BIOLOGICAL RESULTS FROM A PHASE I-II PROOF-OF-CONCEPT CLINICAL STUDY

L. Biard
S. Loisel
V Girault
A Korganow
G. Pugnet
N. Abisror
  • Fonction : Auteur

Domaines

Cancer
Fichier non déposé

Dates et versions

hal-04694725 , version 1 (11-09-2024)

Identifiants

Citer

D. Farge, L. Biard, B. Weil, S. Loisel, P. Lansiaux, et al.. ALLOGENEIC UMBILICAL-CORD DERIVED MESENCHYMAL STROMAL CELLS MSC(UC) AS TREATMENT FOR SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): SAFETY AND EARLY CLINICAL/BIOLOGICAL RESULTS FROM A PHASE I-II PROOF-OF-CONCEPT CLINICAL STUDY. 30th Annual ISCT Meeting, May 2024, Vancouver, Canada. pp.S45-S46, ⟨10.1016/j.jcyt.2024.03.076⟩. ⟨hal-04694725⟩
8 Consultations
0 Téléchargements

Altmetric

Partager

More